Intrasplenic Liver Parenchymal Cells in Conjunction with Low-Dose Rapamycin and Cyclosporine Induce a Unique and Specific Prolongation of Rat Cardiac and Small Bowel Allograft Survival

These experiments investigated the immunosuppressive properties of liver tissue. Brown Norway (BN; RT1 n ) rat heart allografts survived in untreated control Wistar Furth (WFu; RTl u ) rat recipients for 6.2 ± 1.5 days, while allografts in animals that received rapamycin (RAPA) 0.0075 mg/kg/day and...

Full description

Bibliographic Details
Main Authors: Michael J. Boyle M.D., Vano Baghdassarian, Stanislaw M. Stepkowski, Lynette J. Dumble, Barry D. Kahan
Format: Article
Language:English
Published: SAGE Publishing 1998-05-01
Series:Cell Transplantation
Online Access:https://doi.org/10.1177/096368979800700303
_version_ 1811289363481362432
author Michael J. Boyle M.D.
Vano Baghdassarian
Stanislaw M. Stepkowski
Lynette J. Dumble
Barry D. Kahan
author_facet Michael J. Boyle M.D.
Vano Baghdassarian
Stanislaw M. Stepkowski
Lynette J. Dumble
Barry D. Kahan
author_sort Michael J. Boyle M.D.
collection DOAJ
description These experiments investigated the immunosuppressive properties of liver tissue. Brown Norway (BN; RT1 n ) rat heart allografts survived in untreated control Wistar Furth (WFu; RTl u ) rat recipients for 6.2 ± 1.5 days, while allografts in animals that received rapamycin (RAPA) 0.0075 mg/kg/day and cyclosporine (CsA) 0.375 mg/kg/day delivered for 14 days by continuous intravenous infusion (civi) using osmotic pumps in conjunction with intrasplenic (i.s.) saline survived to 18.4 ± 1.3 days. i.s. addition of 3 M-KCl extracted BN hepatic antigen or unpurified BN hepatocytes (liver parenchymal cells—5 × 10 7 /kg), which exhibited a 4.8% class II antigen expression, and which alone failed to prolong allograft survival (MST = 6.0 ± 1.4 days), increased heart allograft survival to 25.3 ± 2.3 and 27.2 ± 1.9 days, respectively (p < 0.01). Hepatocyte purification using Dynabeads and Percoll reduced class II expression to 0.9% and increased allograft survival to 32.8 ± 1.6 days (p < 0.01). In contrast, the effect of 5 × 10 8 /kg BN erythrocytes, exhibiting only 0.1% class II expression, was much less (23.8 ± 1.9 days). Administration i.s. of BN splenocytes or nonparenchymal liver cells, demonstrated by flow cytometry to exhibit a 47.3 or 55.1% expression of class II antigen, respectively, failed to induce any significant increase in allograft survival (18.4 ± 4.6 and 19.4 ± 0.5 days, respectively). Survival of BN rat small bowel allografts was increased in Lewis (LEW; RTl 1 ) rat recipients treated with RAPA, CsA, and unfractionated BN hepatocytes from 10.2 ± 1.9 to 21.2 ± 1.5 days. Pretreatment with i.s. BN hepatocytes, 14 days prior to harvesting, reduced WFu lymphocyte responses to allogeneic stimulation with BN or ACI spleen cells by 75 and 70%, respectively. Addition of 1 × 10 5 unpurified donor-specific BN or third-party Buffalo (BUF; RTl b ) hepatocytes, but not supernatant, to the responder wells of MLCs resulted in a 61 and 40% suppression, respectively, of the WFu lymphocyte response induced by BN allogeneic stimulation. These findings suggest that while class I MHC expression has a significant role to play in exerting the immunosuppressive effects of hepatocytes, other influences more specific to liver may also prevail.
first_indexed 2024-04-13T03:53:33Z
format Article
id doaj.art-b3745370ad6d4314aa612a9ea9127ba1
institution Directory Open Access Journal
issn 0963-6897
1555-3892
language English
last_indexed 2024-04-13T03:53:33Z
publishDate 1998-05-01
publisher SAGE Publishing
record_format Article
series Cell Transplantation
spelling doaj.art-b3745370ad6d4314aa612a9ea9127ba12022-12-22T03:03:42ZengSAGE PublishingCell Transplantation0963-68971555-38921998-05-01710.1177/096368979800700303Intrasplenic Liver Parenchymal Cells in Conjunction with Low-Dose Rapamycin and Cyclosporine Induce a Unique and Specific Prolongation of Rat Cardiac and Small Bowel Allograft SurvivalMichael J. Boyle M.D.0Vano Baghdassarian1Stanislaw M. Stepkowski2Lynette J. Dumble3Barry D. Kahan4Department of Surgery, The University of Texas Medical School at Houston, Houston, TX 77030, USADepartment of Surgery, The University of Texas Medical School at Houston, Houston, TX 77030, USADepartment of Surgery, The University of Texas Medical School at Houston, Houston, TX 77030, USADepartment of Surgery, The University of Texas Medical School at Houston, Houston, TX 77030, USADepartment of Surgery, The University of Texas Medical School at Houston, Houston, TX 77030, USAThese experiments investigated the immunosuppressive properties of liver tissue. Brown Norway (BN; RT1 n ) rat heart allografts survived in untreated control Wistar Furth (WFu; RTl u ) rat recipients for 6.2 ± 1.5 days, while allografts in animals that received rapamycin (RAPA) 0.0075 mg/kg/day and cyclosporine (CsA) 0.375 mg/kg/day delivered for 14 days by continuous intravenous infusion (civi) using osmotic pumps in conjunction with intrasplenic (i.s.) saline survived to 18.4 ± 1.3 days. i.s. addition of 3 M-KCl extracted BN hepatic antigen or unpurified BN hepatocytes (liver parenchymal cells—5 × 10 7 /kg), which exhibited a 4.8% class II antigen expression, and which alone failed to prolong allograft survival (MST = 6.0 ± 1.4 days), increased heart allograft survival to 25.3 ± 2.3 and 27.2 ± 1.9 days, respectively (p < 0.01). Hepatocyte purification using Dynabeads and Percoll reduced class II expression to 0.9% and increased allograft survival to 32.8 ± 1.6 days (p < 0.01). In contrast, the effect of 5 × 10 8 /kg BN erythrocytes, exhibiting only 0.1% class II expression, was much less (23.8 ± 1.9 days). Administration i.s. of BN splenocytes or nonparenchymal liver cells, demonstrated by flow cytometry to exhibit a 47.3 or 55.1% expression of class II antigen, respectively, failed to induce any significant increase in allograft survival (18.4 ± 4.6 and 19.4 ± 0.5 days, respectively). Survival of BN rat small bowel allografts was increased in Lewis (LEW; RTl 1 ) rat recipients treated with RAPA, CsA, and unfractionated BN hepatocytes from 10.2 ± 1.9 to 21.2 ± 1.5 days. Pretreatment with i.s. BN hepatocytes, 14 days prior to harvesting, reduced WFu lymphocyte responses to allogeneic stimulation with BN or ACI spleen cells by 75 and 70%, respectively. Addition of 1 × 10 5 unpurified donor-specific BN or third-party Buffalo (BUF; RTl b ) hepatocytes, but not supernatant, to the responder wells of MLCs resulted in a 61 and 40% suppression, respectively, of the WFu lymphocyte response induced by BN allogeneic stimulation. These findings suggest that while class I MHC expression has a significant role to play in exerting the immunosuppressive effects of hepatocytes, other influences more specific to liver may also prevail.https://doi.org/10.1177/096368979800700303
spellingShingle Michael J. Boyle M.D.
Vano Baghdassarian
Stanislaw M. Stepkowski
Lynette J. Dumble
Barry D. Kahan
Intrasplenic Liver Parenchymal Cells in Conjunction with Low-Dose Rapamycin and Cyclosporine Induce a Unique and Specific Prolongation of Rat Cardiac and Small Bowel Allograft Survival
Cell Transplantation
title Intrasplenic Liver Parenchymal Cells in Conjunction with Low-Dose Rapamycin and Cyclosporine Induce a Unique and Specific Prolongation of Rat Cardiac and Small Bowel Allograft Survival
title_full Intrasplenic Liver Parenchymal Cells in Conjunction with Low-Dose Rapamycin and Cyclosporine Induce a Unique and Specific Prolongation of Rat Cardiac and Small Bowel Allograft Survival
title_fullStr Intrasplenic Liver Parenchymal Cells in Conjunction with Low-Dose Rapamycin and Cyclosporine Induce a Unique and Specific Prolongation of Rat Cardiac and Small Bowel Allograft Survival
title_full_unstemmed Intrasplenic Liver Parenchymal Cells in Conjunction with Low-Dose Rapamycin and Cyclosporine Induce a Unique and Specific Prolongation of Rat Cardiac and Small Bowel Allograft Survival
title_short Intrasplenic Liver Parenchymal Cells in Conjunction with Low-Dose Rapamycin and Cyclosporine Induce a Unique and Specific Prolongation of Rat Cardiac and Small Bowel Allograft Survival
title_sort intrasplenic liver parenchymal cells in conjunction with low dose rapamycin and cyclosporine induce a unique and specific prolongation of rat cardiac and small bowel allograft survival
url https://doi.org/10.1177/096368979800700303
work_keys_str_mv AT michaeljboylemd intrasplenicliverparenchymalcellsinconjunctionwithlowdoserapamycinandcyclosporineinduceauniqueandspecificprolongationofratcardiacandsmallbowelallograftsurvival
AT vanobaghdassarian intrasplenicliverparenchymalcellsinconjunctionwithlowdoserapamycinandcyclosporineinduceauniqueandspecificprolongationofratcardiacandsmallbowelallograftsurvival
AT stanislawmstepkowski intrasplenicliverparenchymalcellsinconjunctionwithlowdoserapamycinandcyclosporineinduceauniqueandspecificprolongationofratcardiacandsmallbowelallograftsurvival
AT lynettejdumble intrasplenicliverparenchymalcellsinconjunctionwithlowdoserapamycinandcyclosporineinduceauniqueandspecificprolongationofratcardiacandsmallbowelallograftsurvival
AT barrydkahan intrasplenicliverparenchymalcellsinconjunctionwithlowdoserapamycinandcyclosporineinduceauniqueandspecificprolongationofratcardiacandsmallbowelallograftsurvival